Chronic cadmium exposure to minimal-risk doses causes dysfunction of epididymal adipose tissue and metabolic disorders
Authors:
Open Access
- 18 December 2024
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 495, 117203
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Cadmium sources, toxicity, resistance and removal by microorganisms-A potential strategy for cadmium eradicationJournal of Saudi Chemical Society, 2022
- Cadmium: An Emerging Role in Adipose Tissue DysfunctionExposure and Health, 2021
- Hyperinsulinemia and insulin resistance in the obese may develop as part of a homeostatic response to elevated free fatty acids: A mechanistic case-control and a population-based cohort studyEBioMedicine, 2021
- Serum Cadmium Levels and Risk of Metabolic Syndrome: A Cross-Sectional StudyBiological Trace Element Research, 2021
- Sodium metavanadate treatment improves glycogen levels in multiple tissues in a model of metabolic syndrome caused by chronic cadmium exposure in Wistar ratsBioMetals, 2021
- Nrf2 activation through the inhibition of Keap1–Nrf2 protein–protein interactionMedicinal Chemistry Research, 2020
- Levels and determinants of adipose tissue cadmium concentrations in an adult cohort from Southern SpainScience of The Total Environment, 2019
- The role of cadmium in obesity and diabetesScience of The Total Environment, 2017
- Changes on serum and hepatic lipidome after a chronic cadmium exposure in Wistar ratsArchives of Biochemistry and Biophysics, 2017
- Adiponectin: mechanistic insights and clinical implicationsDiabetologia, 2012